Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis

Publisher： Karger

E-ISSN： 1421-9751|128|1|34-40

ISSN： 0008-6312

Source： Cardiology, Vol.128, Iss.1, 2014-02, pp. : 34-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycosylated Hemoglobin Is a Predictor of Major Adverse Cardiac Events after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus

By  

Cardiology, Vol. 116, Iss. 1, 2010-05 ,pp. : 51-57

Karger

Access to resources Recommend Favorite

Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study

By  

Cardiology, Vol. 137, Iss. 4, 2017-05 ,pp. : 225-230

Karger

Access to resources Recommend Favorite

Periprocedural myocardial infarction is associated with increased mortality in patients with coronary artery bifurcation lesions after implantation of a drug‐eluting stent

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 696-705

John Wiley & Sons Inc

Access to resources Recommend Favorite

Early healing assessment with optical coherence tomography of everolimus‐eluting stents with bioabsorbable polymer (synergy™) at 3 and 6 months after implantation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : E67-E73

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of policosanol in patients with high on‐treatment platelet reactivity after drug‐eluting stent implantation: two‐year follow‐up results

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 34, Iss. 5, 2016-10 ,pp. : 337-342

John Wiley & Sons Inc

Access to resources Recommend Favorite